ArticleBreast cancer (Tokyo, Japan)2019

Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer.

Hiroshi Ishiguro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.